Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.

about

Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.

Item

http://www.wikidata.org/entity/Q47591626

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@en

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@nl

type

Item

label

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@en

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@nl

prefLabel

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@en

Evaluation of patritumab with ...... tric sarcoma xenograft models.

@nl

P1476

Evaluation of patritumab with ...... atric sarcoma xenograft models

@en

P2093

Abhik Bandyopadhyay

http://www.w3.org/2001/XMLSchema#string

Aron Trevino

http://www.w3.org/2001/XMLSchema#string

Cheryl London

http://www.w3.org/2001/XMLSchema#string

Denis Guttridge

http://www.w3.org/2001/XMLSchema#string

Dias Kurmashev

http://www.w3.org/2001/XMLSchema#string

Doris A Phelps

http://www.w3.org/2001/XMLSchema#string

Edward Favours

http://www.w3.org/2001/XMLSchema#string

Joel Michalek

http://www.w3.org/2001/XMLSchema#string

Kenji Hirotani

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Cross talk of tyrosine kinases with the DNA damage signaling pathways

Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

The genomic landscape of pediatric Ewing sarcoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer.

Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma

Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma.

Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.

P31

scholarly article

P356

10.1002/PBC.26870

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Raushan T Kurmasheva

P577

2017-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29080385

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5739936

http://www.w3.org/2001/XMLSchema#string